Menu
Search
|

Menu

Close
X

Athenex Inc ATNX.OQ (NASDAQ Stock Exchange Global Select Market)

16.19 USD
-0.47 (-2.82%)
As of 11:23 PM IST
chart
Previous Close 16.66
Open 16.49
Volume 19,927
3m Avg Volume 109,695
Today’s High 16.50
Today’s Low 16.08
52 Week High 20.43
52 Week Low 11.25
Shares Outstanding (mil) 57.06
Market Capitalization (mil) 1,076.79
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY17
23
FY16
21
FY15
5
EPS (USD)
FY17
-2.032
FY16
-1.512
FY15
-0.247
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
54.10
5.77
Price to Book (MRQ)
vs sector
9.01
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
5.96
16.52
LT Debt to Equity (MRQ)
vs sector
4.38
12.22
Return on Investment (TTM)
vs sector
--
14.43
Return on Equity (TTM)
vs sector
--
16.13

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

1001 Main St Ste 600
BUFFALO   NY   14203-1009

Phone: +1716.8988625

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company offers Oraxol, an oral formulation of paclitaxel; Orateacan, an oral formulation of Irinotecan; Oradoxel, an oral formulation of Docetaxel, and an oral formulation of Topotecan for the treatment of various types of cancers. Its Src Kinase Inhibitors include KX-01 (KX2-391) and KX-02 (KX2-361) oncology drug candidates. The Company's Symptom Therapeutics include CQ-01, which is used for the treatment of burn pruritus and scars; CQ-R1, which is used for the treatment of an irradiation-induced dermatitis, and an intranasal Granisetron used for the treatment of chemotherapy-induced nausea/vomiting.

SPONSORED STORIES